Methyl-donor supplementation in women with systemic lupus erythematosus with different nutritional status: the protocol for a randomised, double-blind, placebo-controlled trialJhulia C N L da Mota, Lucas M Carvalho, Amanda A Ribeiro, Leticia L Souza, Eduardo F Borba, Hamilton Roschel, Bruno Gualano, Carolina F Nicoletti
7 October 2024
Correction of omega-3 fatty acid deficiency and improvement in disease activity in patients with systemic lupus erythematosus treated with krill oil concentrate: a multicentre, randomised, double-blind, placebo-controlled trialJane Salmon, Daniel J Wallace, Violeta Rus, Addison Cox, Claire Dykas, Brooke Williams, Yunpeng Ding, Petter-Arnt Hals, Line Johnsen, Peter E Lipsky
14 July 2024
Mezagitamab in systemic lupus erythematosus: clinical and mechanistic findings of CD38 inhibition in an autoimmune diseaseScott R P McDonnell, Van Anh Nguyen, Noah M Walton, Carsten Merkwirth, Feng Hong, Deborah Berg, Elena Tomaselli Muensterman, Richard A Furie
7 March 2024
Evaluation of RNase therapy in systemic lupus erythematosus: a randomised phase 2a clinical trial of RSLV-132Daniel J Burge, Victoria P Werth, Susan A Boackle, James Posada
7 February 2024
Fragility of randomised controlled trials for systemic lupus erythematosus and lupus nephritis therapiesGabriel Figueroa-Parra, Michael S Putman, Cynthia S Crowson, Alí Duarte-García
10 January 2024
Efficacy and safety of telitacicept in patients with systemic lupus erythematosus: a multicentre, retrospective, real-world studyHui-Zhi Jin, Yu-jing Li, Xin Wang, Zhijun Li, Bin Ma, Lin Niu, Peng Wang, Hai-feng Pan, Si-dong Li, Wei Bao, Guosheng Wang, Xiao-mei Li, Zhu Chen
24 November 2023
Utility of the ACR-1997, SLICC-2012 and EULAR/ACR-2019 classification criteria for systemic lupus erythematosus: a single-centre retrospective studyWentian Lu, Ying Zhong, Chenghua Weng, Qing Wang, Mei Tang, Zhichun Liu, Leixi Xue
8 September 2022
Safety, immunological effects and clinical response in a phase I trial of umbilical cord mesenchymal stromal cells in patients with treatment refractory SLEDiane L Kamen, Caroline Wallace, Zihai Li, Megan Wyatt, Crystal Paulos, Chungwen Wei, Hongjun Wang, Bethany J Wolf, Paul J Nietert, Gary Gilkeson
12 July 2022
Sirolimus versus tacrolimus for systemic lupus erythematosus treatment: results from a real-world CSTAR cohort studyNan Jiang, Mengtao Li, Hongfeng Zhang, Xinwang Duan, Xiaofeng Li, Yongfei Fang, Hongbin Li, Pingting Yang, Hui Luo, Yanhong Wang, Liying Peng, Jiuliang Zhao, Chanyuan Wu, Qian Wang, Xinping TianSee the full list of authors
3 January 2022
Peripheral neuropathy in systemic lupus erythematosus: what can neuromuscular ultrasonography (NMUS) tell us? A cross-sectional studySafaa A Mahran, Felice Galluccio, Tayseer Mohamed Khedr, Amira Elsonbaty, Abdallah El-Sayed Allam, Alvaro Garcia Martos, Doaa M M Osman, Marco Matucci-Cerinic, Serena Guiducci, Marwa A A Galal
26 July 2021